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Abstract
Electroporation is the critical step in an electric field mediated drug or
gene delivery protocol. Electroporation based protocols have been successfully
demonstrated in cancer clinical trials, however, its impact in other applications is
still under investigation. A significant roadblock to long term functioning of
implantable biosensors in vivo is the tissue reaction in the form of fibrous
encapsulation that results in reduced transport to the sensing element of the
biosensor. In vivo gene electroporation has a great potential as a means to
modify the transport properties of tissues in the proximity of the sensing element
of implantable biosensors.
This

dissertation

examines

two

postulated

electroporation

based

strategies to modify tissue for enhanced performance of an implantable
biosensor. In the first, the implantation protocol is modified to accommodate in
vivo electroporation. In the second strategy, the the modification is applied post
implantation. This post-implantation in vivo electroporation application requires
that electric energy be delivered at the site of electroporation close to the
biosensor while minimizing effects far from such site. A novel method, focusing
electric fields, developed for this purpose is presented. A theoretical framework
as well as in vitro and in vivo experiments are provided as the introduction to the
method and in support of its potential as the basis of a viable technology.

viii

Chapter 1. Prelude
The manuscript before you summarizes my research on the problem
presented to me at the start of my doctoral studies. This challenge represents
the convergence of two different technologies that were being developed at the
University of South Florida (USF, Tampa, FL). The first technology consists of a
subcutaneous implantable glucose biosensor being developed at the time by the
USF Biosensors and Biomaterials Laboratory, an interdisciplinary team under the
direction of Dr. Francis Moussy (currently at the World Health Organization,
Switzerland). The second technology, in vivo electric field mediated drug and
gene delivery, is part of the ongoing technology development work at the USF
Center for Molecular Delivery which is led by Dr. Richard Gilbert.
The proposed work was to define requirements for an in vivo
electroporation protocol capable of delivering therapeutic molecules to tissue
surrounding the sensing element of the implantable glucose biosensor. The
appropriate therapeutic molecule candidates to be delivered would then be
selected to solve a roadblock which is common to many implantable sensing
devices: the development of collagenous fibrous encapsulation of the sensing
element that impedes the transport of molecules, hence, hindering the
functionality of such biosensor, shortening its performance life cycle. In the case
of the implantable biosensor, the candidate molecules could be DNA coding for
1

neovascularization factors such as Vascular Endothelial Growth Factor (VEGF),
which have the potential of increasing the transport properties of tissues.
From the early stages of this research project, two research pathways
were evident. These pathways originated from the inability to predict the timing
of the sequence for biological tissue response events following the implantation
of the glucose biosensor.

One pathway is to investigate the delivery of

therapeutic molecules at the time of implantation of the biosensor. The other
approach is to develop a method that increases the effectiveness of delivery of
therapeutic molecules in deep tissue that is not in direct contact with the
electrodes used to deliver the electric fields.
The body of the work represented in this dissertation advances the
knowledgebase needed to solve the interdisciplinary problem associated with the
fibrous encapsulation at the glucose biosensor. It demonstrates how electric field
mediated gene delivery brings the solution to that problem a step closer by
defining a viable tissue engineering application. In addition, the research results
provide a wealth of potential technological advancement in the study of in vivo
electroporation itself, as well as modeling tools and techniques to develop
applicable electric field mediated drug and gene delivery protocols to tissue
engineering.

2

Part I

3

Chapter 2. Literature Review
This review begins with an overview of implantable glucose biosensors to
accent the current state of the technology as it relates to this work. Biosensor
design, implantation procedure, and tissue reactions to implanted biosensors are
presented. Electric field mediated drug and gene delivery is then introduced from
a historical perspective with its applications.

Finally, tissue engineering

applications as they relate to this project are presented.
2.1. Implantable Glucose Biosensor
2.1.1. Glucose Biosensor Design
The implantable glucose biosensor at the core of this project [1] was the subject
of intensive development by the “USF Biosensors and Biomaterials Laboratory.”
The laboratory has led several efforts to improve the function and reliability of the
sensor under implanted conditions. This micro-implantable glucose sensor is an
amperometric enzyme biosensor that includes a reference electrode and a
sensing element.

The sensing element is loaded with glucose oxidase and

protected by several layers of porous polymeric materials that improve the
biosensor’s biocompatibility, durability, and sensitivity. The biosensor’s sensing
element is made of a 0.125 mm diameter platinum-iridium wire coiled around a
cotton fiber with glucose oxidase, surrounded by an enzyme layer within a

4

Figure 2.1. Implantable glucose biosensor [2]. Reproduced with permission
from Wiley.
Nafion® layer coated with an external Epoxy-PVC layer. This forms a cylindrical
element roughly 0.5 mm in diameter by 1 mm long. The reference electrode is
0.125 diameter silver wire coated with Teflon which is about 2 to 4 mm away
from the sensing element [2, 3]. Figure 2.1 shows a diagram of the glucose
biosensor with a detail of the reference electrode, sensing element, enzyme
loaded volume, and protective layers. In this biosensor design, the immobilized
glucose oxidase enzyme catalyzes the oxidation of glucose using oxygen to
produce gluconoloctone and hydrogen peroxide; the hydrogen peroxide is then
measured at the electrode when it oxidizes and produces an electrical current
proportional to the oxidized glucose concentration [4].

5

2.1.2. Implantation Procedure
Preclinical testing of such biosensors has required development of
implantation techniques that are adequate to improve sensor survival in animal
models, and can potentially be translated to humans when the biosensors are
ready for clinical testing [5].

Current efforts to improve the long term function

and bio-stability of the implanted biosensor include cross-linked porous scaffolds
that surround the sensing element of the biosensor by potentially minimizing
tissue reactions while stimulating angiogenesis around the sensing element of
the biosensor [6]. The current pre-clinical glucose sensor implantation procedure
is designed to test biosensor reliability in vivo using Sprague-Dawley (SD) rats.
The biosensor is implanted subcutaneously leaving two contacts for electrodes

Figure 2.2. Preclinical glucose biosensor implantation procedure.

6

protruding from the back of the animal. It was designed to simulate a potential
clinical use of the biosensor while keeping the practicality of animal testing. The
experimental design allows that periodic measurements be made using an
external commercial potentiometer.
In the case of the glucose biosensor of interest, the implantation protocol
involves the use of a 16 gauge punch needle inserted subcutaneously in which
the biosensor is inserted and left in place when the needle is then removed; the
technique is designed to immobilize the sensor and reduce complications related
to the procedure and post-procedure recuperation [7]. Figure 2.2 shows the
initial implantation procedure in which the needle cannula is inserted (1), followed
by the insertion of the implantable biosensor in the exiting end of the cannula (2),
and removal of the cannula to leave the implantable biosensor in place. The
biosensor can be affixed to the tissue using sutures. In clinical applications, the
biosensor would not protrude to the exterior, but would use wireless protocols to
provide real time glucose data.
2.1.3. Tissue Reactions to Implantable Biosensor
Tissue reactions to implants are dependent on a myriad of factors. These
factors include but are not limited to the extent of the injury created at the time of
the implantation procedure, characteristics of the animal model, tissues affected,
geometry of the implant, materials of the implant, and other characteristics of the
implant [8]. In the case of biosensors, such as the glucose biosensor, the tissue
reactions have an added complexity that is attributed to the applied potential for

7

amperometric measurements and production of hydrogen peroxide as a result of
the reduction-oxidation reaction.
Chronologically, the response to the implantable glucose sensor starts
with the injury caused by the implantation procedure and is followed by bloodmaterial interactions [10].

These responses include a provisional matrix

formation, inflammation, granulation of tissue, foreign body reaction, and finally,
fibrous encapsulation and loss of vasculature that decreases the transport of
glucose and oxygen to the sensing element of the biosensor, resulting in loss of
function [9, 11-13]. Figure 2.3 shows a generalization of the temporal variation of
such processes including the type of cells and tissue reactions. The migration of
neutrophils starts with the inflammation process, and is followed by macrophage
migration. Neovascularization allows further migration of foreign body giant cells

Intensity

ACUTE

CHRONIC

GRANULATION TISSUE

Neutrophils

Macrophages
Neovascularization
Foreign Body
Giant Cells
Fibroblasts
Fibrosis
Mononuclear
Leukocytes
4 weeks Time

Figure 2.3. Temporal variation in the acute and chronic inflammatory,
granulation tissue development, and foreign body response to implanted
biosensor. Adapted from Anderson, 2001 [9].
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and fibroblasts which are responsible for the fibrous encapsulation. Of particular
interest for this project is the fibrosis process, which has an adverse effect in the
transport of glucose and oxygen to the sensing element of the implantable
biosensor in a matter of weeks. A study by Bazhang Yu et al., performed in 2006
in the former Biosensors and Biomaterials Laboratory at the University of South
Florida confirmed that while the glucose biosensor can properly function for 3 to
4 months continuously in vitro, when implanted in vivo.

It generates tissue

reactions, as those shown in Figure 2.3, that make it unreliable after 4 weeks
post implantation [14].
2.2 Historic Perspective of Electroporation
Historically, electric field mediated drug and gene delivery has been used
as an effective method for altering the behavior of targeted biological systems.
The developments in the field of electroporation have been achieved gradually,
and by different groups working on several applications in parallel. This section
introduces a perspective of this technology reflecting its applications, challenges
and successes in living systems.
2.2.1. Electroporation as a Transport Mediating Process
Electroporation as a transport enhancement process in biological systems
has its beginnings in the early 1960’s with the use of electric fields to irreversibly
break down cellular components and to extract materials from animal and plant
tissues [15]. The direct effect of electric fields on cell membrane permeabilization
was characterized in the later years of the 1960’s decade in unicellular biological
9

systems (bacteria, yeast, protoplasts, and suspended mammalian cells) by
Hamilton and Sale [16-18]. In the beginning of the 1970’s, Neumann et al. [19]
proved that cell membranes could be permeabilized reversibly by the application
of electric fields to facilitate molecular transport. Nevertheless, the reversibility of
the electric field induced permeabilization of the cell membrane was a
phenomenon already implicitly understood from experiments in the early 1950’s
by Hodgkin [20, 21].
2.2.2. Plant Applications
The early research on plant gene electroporation was first reported in
protoplasts in 1985 by Fromm et al. [22] and later on intact plant cells by
Hiromichi et al. in 1986 [23], directly into leaf tissue of rice plants by Dekeyser et
al. in 1990 [24]; and in pollen by Matthews et al. in 1990 [25]. The main
application of plant gene electroporation is to produce genetically modified plants
by stably transferring genes that confer desired qualities such as disease or
pesticide resistance to the next generation of plants [26]. Several strategies with
different complexities exist to modify the genome of such plants. In the case of
plant cells and tissues, the strategy is to isolate transformed cells and regenerate
a complete genetically modified plant from such cells.

In a second strategy

which circumvents many problems of plant regeneration from pollen, germinating
pollen can be genetically modified producing genetically modified plants, or
pollen can be transformed before fertilization and then transferred to the stigma
of a plant for germination [27].

10

2.2.3. Animal and Human Cancer Applications
Intensive interest on in vitro electric field mediated gene transfer research
began in the 1980’s with the application of electroporation to mammalian cells by
Wong [28], Neumann [29], and Potter [30].

These studies use multiple

exponential decay high field pulses (4,000 V/cm to 8,000 V/cm) with relative
short duration (5 μs to 25 μs).

Such early work in conjunction with the

investigations on cell electropermeation by Crowley et al. [31] on electrical
breakdown of synthetic lipid membranes, Zimmerman et al. [32] on reversible
membrane permeabilization as it applies to electrofusion, and Tessie et al. [33]
on bilayer lipid vesicle electroporation, opened the discussion for the first time to
the biophysical aspects of gene transfer in cells. Neumann et al. [29] proposed
that the mechanism of transmembrane transfer of DNA would be due to either
electric field activated transmembrane transport protein, or an unspecified
electrobiophysical aspect related to membrane ‘defects’.
In humans, electroporation protocols are mainly used for two different
types of applications. In one, cell membrane impermeable small molecules such
as chemotherapy agents are delivered in cancer applications. In the second
application, electroporation is used to deliver genes packaged in plasmid DNA
with the purpose of having tissues produce proteins of therapeutic value; most
prominent

of

such

application

are

cancer

DNA

electroporation.

Electrochemotherapy, or the use of anticancer drugs in combination with
electroporation was first used in solid tumors and reported animal preclinical
trials [34], and human trials [35-39] in the 1990s. In this cancer application of
11

electroporation, the tumor anticancer effects of chemotherapeutic agents such as
bleomycin [34-36, 39] and cisplatin [38] can be greatly increased. Several animal
models have been explored including hepatoma of the liver [40, 41], and
melanoma among others [42, 43]. In vivo gene delivery via an electroporation
mechanism holds promising applications in cancer treatment, as it is an effective
way to deliver therapeutic genes to accessible tumors with the purpose of
producing a therapeutic proteins such as those in the Interleukin family [41, 44].
The culmination of these investigations has resulted in Phase I clinical trials that
demonstrated its

safety and generated data paving the way for the use of

electric field mediated gene delivery as a potential treatment for metastatic
melanoma [45].
2.2.4. Tissue Engineering Applications
Tissue engineering via gene delivery to functionalize tissues has been
used for a variety of applications that involve transplanted and host cells.
Applications that use transplanted cells are divided into three classes. The first
one, called autografts, involve the same individual’s cells from a different site.
The second, allografts involve cells from the same species but a different
individual.

The third class of transplant is xenografts, which involve cells or

tissues from a different species. Additionally, applications that use host cells can
involve tissue scaffolds that allow migration, or can involve the cells within tissue
that are modified in situ.
Specifically in the case of implantable biosensors, two studies that use
neovascularization genes are worth highlighting. In the first, the use of ex vivo
12

gene therapy showed encouraging results by allowing the improvement of the
functioning of a glucose biosensor in a chicken embryo model by the introduction
of a gene coding for vascular endothelial growth factor (VEGF), into chicken
fibroblast cells, which then were transplanted into a chicken embryo
chorioallantoic membrane (CAM) [46].

This approach used retroviral gene

delivery, which might not be the optimal method for the demands of the
biosensor application due to safety reasons among others.

In another

application, a micro osmotic infusion pump was used to deliver VEGF protein
during 28 days to create neovascularization with the purpose of improving a
glucose biosensor’s function [47].
Electroporation is an effective method in any of these strategies, on either
cells or tissues, and at any step of the processes.

Cells in tissues are

functionalized by electroinserting DNA coding for biologically relevant proteins, or
directly functional RNA such as messanger RNA (mRNA) [48] and interference
RNA (iRNA) [49]. In vivo electroporation has been used effectively in several
tissue engineering applications to modify tissue function. In one, Kishimoto et al.
2002 [50] generated ectopic bone formation in mouse muscle tissue using bone
morphogenetic proteins (BMP) in specific, electroporating a plasmid coding for
BMP-4 gene.

In another tissue engineering application, this time relevant to

wound healing, Ferraro et al. 2009 delivered a plasmid coding for VEGF to rat
skin flaps promoting neovascularization and thus improving wound healing by
reducing ischemia and tissue necrosis [51].
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Chapter 3. Materials and Methods
3.1. Gene Electroporation Experiments
3.1.1. In Vivo Gene Electroporation Protocol
This protocol effectively modifies the implantation procedure developed by
the USF Biosensors and Biomaterials Laboratory [3]. It adapts the procedure to
add in vivo gene electroporation. Electric field parameters were selected based
on previous experience and simulation results (COMSOL Multiphysics, Comsol
Inc., Los Angeles, CA). The cannula used in the implantation protocol is also
used as one of the electrodes to apply the electric field.
Figure 3.1 shows a photograph of the surface electrode and the cannula
electrode.

The photograph shown in Figure 3.1a is a close-up of the two

electrodes positioned in proximity one to the other in a similar fashion as they
were positioned in vivo. The image in Figure 3.1b shows the two electrodes
separately. The cannula electrode consists of a 14 gauge 2” long commercially
available Surflo® I.V. catheter (Terumo Medical Products, Somerset, NJ)
attached to a handle providing an electrical contact. The curvature of the surface
electrode was derived from measurements performed on animal cadavers using
the same cannula electrode below the animal skin at the same anatomical
location of the implantation site. From these measurements, the thickness of the

14

skin from the cannula location to the surface was determined to be 1.7 mm at the
site of implantation.

Figure 3.1. Cannula electrode and surface electrode applicators used in
implantable biosensor electroporation. Permission from the Center for Molecular
Delivery.
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Figure 3.2. In vivo gene electroporation procedure. Permission from the Center
for Molecular Delivery.
The plasmid construct selected for this study was gWIZ Luciferase
(Aldevron, Fargo, ND). The map for this plasmid is shown in Figure 3.3. The
construct contains a modified human cytomegalovirus virus (CMV) promoter for
increased protein expression in mammalian systems.

The promoter site is

located between the Ndel-183 and Sall-1874 restriction endonuclease cutting
sites. The coding region of the plasmid contains a firefly gene that expresses
luciferase protein and is located between the Sall-1874 and BamHI-3590
restriction enzyme cutting sites. When used in this protocol, and if expressed in

16

vivo, the gene results in firefly luciferase protein. The detection of this expression
is explained in detail in the next subsection.

Figure 3.3. Luciferase plasmid used to deliver tracer gene, gWIZ Luc. Source
Aldevron, Fargo, ND.

3.1.2. In Vivo Bioluminescent Imaging
In vivo biolumninescent imaging was used as a tool to measure Luciferase
gene expression from the tracer gene study. This method was first reported as
used for in vivo electroporation in 2001 by Honigman et al. using in vivo
bioluminescent detection by charge coupled device (CCD) camera to detect
Luciferase expression [52].

The imaging procedure follows.

At 0 (before

electroporation), 1, 4, 8, 15, and 22 days, animals were injected with 150 μg of Dluciferin (Xenogen Corporation, Hopkinton, MA) per gram of body weight in saline
solution and images were acquired using a cooled CCD camera (IVIS 200,
17

Xenogen Corporation). Images were analyzed and bioluminescence quantified
using photonics information based analysis software (Living Image, Xenogen
Corporation). The quantification was executed using circular regions of interest.
Results were then statistically analyzed using Student’s t-test.
Figure 3.4 shows a representation of the in vivo imaging protocol. The top
panel shows the reaction in which luciferase expressing protein oxidizes the
luciferin substrate producing oxyluciferin and a photon. The photograph below is
a superposition of the light image of a rat with two electroporated sites producing
light. The pseudocoloring represents the photon flux with red being the highest
emission and blue the lowest level.

The panel to the right shows the

Figure 3.4. In vivo imaging protocol. Permission from the Center for Molecular
Delivery.
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intraperitonial injection of luciferin substrate (Figure 3.4a), and a representation
of the rat imaging within the Xenogen IVIS system.
3.2. Electric Field Focusing Experiments
3.2.1. In Vitro Electric Field Focusing Experiments
Cells cultured for in vitro experiments were B16F10 adherent murine
melanoma cells (ATCC CRL6475, American Type Culture Collection, Manassas,
VA). The culture medium used for B16F10 cells is McCoy’s 5A (Mediatech,
Manassas, VA) medium with 10% fetal calf serum and 90 µg/ml of gentamicin
sufate (Mediatech) as antibiotic. Culture previous to experiments is done in an
incubator at 37ºC and 5% CO2. The cells were detached from culture flasks
using trypsin EDTA (Mediatech) and placed in 60mm culture dishes (Culture
surface of 20cm2). The cell density used for in vitro experiments was of 204,000
cells/cm2, which corresponds to about 4 million cells per each 60mm culture dish.
Cells are cultured for 18 hours in dishes and wells to assure cell attachment to
the bottom of the culture dish. Calcein (C30H26N2O13, Sigma-Aldrich, Inc., St.
Louis, MO) was used as a fluorescent tracer molecule. Calcein is a membrane
impermeable molecule that will effectively enter cells after the cells have been
exposed to an electric field.
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Figure 3.5. Design of electrodes and floating rectangular inserts. [53].
For the purpose of electric field focusing, a customized in vitro applicator
was required.

The primary design constraint for this unique electroporation

applicator was the need to deliver electric fields on the bottom of a 60 mm culture
dish containing adherent B16F10 cells.

A diagram for this applicator

superimposed on a 60 mm cell culture dish is illustrated in Figure 3.5. The figure
shows the 4 stainless steel needle electrodes symmetrically placed near the
circumference of the applicator as a vertically positioned electrode pair,
electrodes 1 and 2, and a horizontal electrode pair, electrode 3 and 4. The
diagram also indicates four rectangular elements at the center of the culture dish.
These 4 plates work as “floating electrodes” since they are non-grounded. They
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are placed in a “cross” configuration at the center of the dish. These elements
are held in place on top of the cell culture dish using a Teflon™ (Small Parts,
Miami, FL) rod which guarantees they are electrically insulated. The electric
fields were applied through pairs of opposing electrodes at the time using an
Electro Square Porator™ ECM 830 (BTX – Harvard Apparatus, Inc., Holliston,
MA) pulse power generator.
Previous to exposure to electroporation, the media in the culture dish was
removed, and the surface of the dish was covered with 2 ml of a 120 µM calcein
phosphate buffer solution (PBS, Mediatech). The applicator's electrodes and 4
rectangular “floating electrodes” were brought into contact with the surface of the
of culture dish where the B16F10 cells were cultured. Each pair of electrodes (12, or 3-4) was used to apply four pulses in each direction with a potential
differential of 1,500 V (equivalent to a nominal electric field of 375 V/cm) for a
total of 16 pulses, pulse duration was of 150 µs and the interval between pulses
was of 500 ms. The calcein treated cells were rinsed three times with PBS
following a 30 minute incubation time but prior to cell florescence intensity
detection.

The control experiments were also analogous to the in vitro

parameter optimization experiments except for the placement of the four plates in
the center of the dish.
3.2.2. In Vivo Fluorescent Dye Uptake by Electric Field Focusing
C57BL/6J mice were injected in a single flank with one million B16F10
mouse melanoma cells in a volume of 50 µL to induce solid tumors. The tumors
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were monitored daily and allowed to develop for 7-10 days yielding tumors
approximately 4 mm to 6 mm in diameter. Once the tumors were established,
the mice were treated.
Polystyrene microspheres (Polysciences, Inc., Warrington, PA) were
suspended in 60M SYTOX® green (S7020, Invitrogen, Carlsbad, CA) dye
solution. SYTOX® green is a nucleic acid stain that will stain nuclei cells with a
compromised cell membrane.

Fuorescence is proportional to the fraction of

permeabilized cells. SYTOX® green is positively charged with a net +3 charge

Figure 3.6. Parallel plate electrode used on tumors for electric field focusing in
vivo experiments.
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[54]. Microspheres used for the fluorescent study were 25 m NIST traceable
polystyrene microspheres (Polysciences). Melanoma tumors were extracted and
stored in 20% sucrose in 0.01 M phosphate-buffered saline (PBS) at 4 °C for 2
days. Tumors were then rapidly frozen with dry ice and sectioned with a
cryogenic microtome (Cryostat E110, Thermo Fisher, Kalamazoo, MI). Series of
50-μm-thick sections of the tumors were deposited in microscope slides and fixed
for fluorescent microscopy.
Fluorescent imaging was accomplished using an Olympus FV1000 MPE
Multiphoton Laser Scanning Probe (Olympus America, Center Valley, PA) in
confocal mode and using a 4X and a 40X water submersible lens for larger and
smaller field of view respectively. Fluorescent confocal (showing cell nuclei) and
optical images (provided location of microspheres in xy plane) were recorded
throughout the tumor sections. Using MATLAB, peak fluorescence (in arbitrary
units) at cell nuclei was measured from 6 images representing different planes in
sections of tumors. Fluorescence was measured radially from the location of
microsphere edges. Peak fluorescence was then normalized to maximum
fluorescence.

This yielded normalized nuclei fluorescence as a function of

distance from the edge of the microsphere. Maximum electric fields calculated
from the microsphere edge were extracted from modeling results, then divided by
applied nominal electric field as explained in the previous section.

This

maximum electric field was statistically correlated to the fluorescence using a
logistic function.
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3.2.3. Electric Field Focusing for Electrochemotherapy
The preparation of tumor bearing mice for the electrochemotherapy
experiment was carried out using the same animal melanoma tumor model in the
previous section. Additionally, mice were divided into eight groups consisting of
8 to 12 mice per group. The first group was the control group that received
saline injection as treatment, the other seven groups received saline and electric
pulses, bleomycin only, bleomycin and electric pulses, microsphere-saline
suspension,

microsphere-bleomycin

suspension,

and

microsphere-saline

suspension plus electric pulses, microsphere-bleomycin suspension plus electric
pulses.

Bleomycin stock solution (Sigma Aldrich, St. Louis, MO) was

reconstituted in normal saline solution to a concentration of 4 units/mL so that
each 50 L injection volume contained 0.2 units of bleomycin to match a
concentration used in a intratumor ECT protocol developed by Heller et al. [43] .
Normal saline solution was used for groups using saline, and 20 µm Polybead®
polystyrene microspheres (Polysciences) were used at 6•103 microspheres per
mL of saline solution for the microsphere groups. Microspheres in solution were
centrifugated and the microspheres resuspended in the appropriate solutions.
Bleomycin is a positively charged chemotherapy molecule that destroys DNA and
is endocytosed by the cell. The uptake of bleomycin is greatly increased by
electroporation mechanisms [55].
Parallel plate electrodes consisting of 2x2cm flat stainless steel plates
mounted on a vernier caliper were used. The calipers (shown in Figure 3.6)
allow the measurement of the distance between the plates and therefore the
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adjustment of the potentials so that pulse electric field intensity may be kept
constant. These electrodes were placed to deliver a voltage potential across the
shortest side of tumors.

Conductive electrocardiography gel (Spectra 360

electrode gel, Parker Laboratories, Inc., Orange, NJ) was applied to each
electrode to guarantee adequate electrical contact between the electrodes and
the skin. Electrochemotherapy and control treatments consisted of a single
treatment (Day 0) consisting of a single intratumor injection followed by 8 pulses,
(four initial pulses followed by four with inverted polarity). Pulses applied were
1,300 V/cm electric field intensity (nominal field) with a duration of 100 s and 1 s
duty cycle following well established electrochemotherapy protocols used in the
same animal model [42, 43]. Tumors were followed for 30 days every third day.
Tumor volumes (V) were calculated using the following formula:

V=L·W·H·

π
6

(3.1)

where L (mm) was the longest dimension of the tumor, W (mm) was the shortest
direction of the tumor, and H (mm) was the height of the tumor as measured
using millimeter calipers. Per protocol, animals were humanely euthanatized and
removed from the survivorship list if total tumor volume reached 1,500 mm3.

25

Chapter 4. Modeling Electric Fields for Electroporation
4.1. Introduction
Model development for electric field mediated drug and gene delivery
applications must explore the possible impact of protocols on target tissues. This
chapter explains the most relevant considerations and principles for model
development.

It presents elements that demonstrate the adequacy of the

modeling platform so that it may be applied to model in vivo and in vitro
phenomena as it relates to applied electric field in tissues.
Electric field mediated in vivo agent delivery protocols use electroporation
(EP) or electropermeabilization to facilitate the transport of molecules across the
cell membrane and into the cell. In vivo EP occurs when short electric pulses are
used to permeabilize cell membranes in tissues and thus improve uptake of
therapeutic molecules into cells. These applied electric fields generate three
populations of cells within treated tissues.

First, cells which are reversibly

electroporated, that receive the right amount of energy to permeabilize and
considerably increase the uptake of therapeutic molecules, but regain cell
function after membrane stabilization. Second, a population of cells that received
a marginal quantity of energy and are not affected significantly.

And last, a

collection of dead cells that result from receiving an excess of energy.

The

excess of energy may result in irreversible permeabilization of cell membranes.
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Cell death occurs for the most part close to the electrodes where electric field
intensity is higher, and where undesired effects such as joule heating and
electrochemical reactions are also most likely to occur.
The most investigated clinical application of in vivo EP is the treatment of
solid tumors in cancer [35-37, 45]. As indicated in chapter 2, two modalities of
electroporation are used in the treatment of cancer.

In the first one,

Electrochemotherapy (ECT), high field strength pulses are applied in combination
with chemotherapeutic agents. The most common used chemotherapy agents
for ECT are bleomycin or cisplatin.

In the second cancer application, the

membrane permeabilization provided by electric field pulses has been used to
increase the uptake of anticancer genes such as interleukins. Both ECT, and in
vivo electrogene therapy protocols, were developed in animal studies and then
applied in clinical trials to treat solid tumors [34, 39, 41, 44, 56, 57].
In vivo electric field mediated delivery protocols require direct application
of a potential differential across the targeted tissue. Different electrode systems
(commonly called applicators), pulse duration and magnitude have been
developed to match the specific target tissue and therapeutic molecule delivered.
Depending on how deep into an organ the effect is desired, electric fields can be
applied on the surface of organs, or into deeper tissue. Applicators designed for
use on the surface of organs such as the skin use plate electrodes, skin
pinching[58], or surface needle electrodes [59]. Surface electrodes can also be
placed on catheters and used in hollow organs such as within the cardiovascular
and digestive systems [60]. Applicators that use electrode arrays allow multiple
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combinations of electrode pairs to deliver more uniform distributions of electric
fields.
4.2. In Silico Design of Gene Electroporation Applicator
The generalized electrostatics module of the Comsol Multiphysics 3.3
modeling software was used to model and analyze the distribution and intensity
of the electric fields.

This module permits modeling of dielectric media and

conductive materials in a single model.

Thus, the animal tissue, and the

evaluation of conductive materials such as the electrodes and other conductive
objects can be assessed in a single model. The following are the subdomain
COMSOL defined partial differential equations (PDE) and boundary equations
[61].

Equation 4.1 describes the subdomain PDE generalized electrostatics

COMSOL mode, and originates from the quasistatic approximation summarized
later in this chapter.
-൫ሺσ+jωε0 εr ሻV൯=0

(4.1)

where σ is the conductivity of the material (S/m), ε0 is the permittivity of free
space (8.8542.. F/m), εr is the relative permittivity of the material, ω is the angular
frequency, and V is the gradient of the potential differential equivalent to the
electric field vector, E. The constitutive relationship defines the electric field flux
vector, D:
(4.2)

D=ε0 εr E
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The boundary conditions are defined as follows: Equation 4.3 indicates the
continuity boundary condition, equation 4.4 defines the boundaries at the
external limits of the model, and equation 4.5 indicates the electric potential
boundary condition.
n·ሺJ1 -J2 ሻ=0

(4.3)

n·J=0

(4.4)

V=V0

(4.5)

where n represents the normal vector, J represents the current density vector,
the subscripts 1 and 2 refer to values of current in the boundary between
adjacent elements, and V0 refers to a potential value which if equal to zero
represents a ground potential, and if different than 0, an applied potential.
Two in silico models were constructed using numerical methods to solve
the equations described above.

The first model uses a 3D geometry, and

represents to scale, two surface electrodes on which the potential is applied.
The model includes the cannula that is used to insert the implantable biosensor
and is located in the rat subcutaneous tissue at the moment of the
electroporation.

The cannula is not electrically connected to any of the

electrodes or ground.

The second model also uses a 3D geometry, and

represents to scale, a single surface electrode, and the cannula described above,
with the difference that the cannula in this case is an electrode. The results from
the modeling of these applicator design options are later discussed later in
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chapter 8. The method is also used in chapter 9 to simulate electric fields for in
vitro and in vivo applications of electroporation.
4.3. Electroporation Pulse Properties
Model development for electric field mediated drug and gene delivery
must incorporate pulse properties. Electroporation pulse design is also specific
to the application. Rectangular pulses are by far the most common pulses used
for in vivo EP. In general, the duration of electric fields used have evolved into
four different time scales[62].

Millisecond (1-200ms) duration pulses with

magnitudes in the range of 10-500 V/cm have been typically used for large
molecule delivery, as is the case of DNA vectors containing genes. Microsecond
duration pulses (1-500μs) with magnitudes in the range of 100-2,000V/cm have
been used to deliver smaller molecules such as chemotherapy agents and small
tracers such as fluorescent dyes. More recently, nanosecond pulses (5-500ns)
and electric fields with magnitude above 30,000 V/cm have been used to
irreversibly electroporate cellular compartments of membranes causing apoptosis
in tissues [63]. Finally, subnanosecond pulses (100-999ps) with electric field
magnitude above 150,000 V/cm [64] which share many characteristics as
nanosecond pulses. The magnitude of the electric fields necessary to generate
the electroporation effects increase as pulse duration decreases.
Figure 4.1 provides a comparative representation of the electromagnetic
spectrum with well known entities for comparison.

The figure includes the

electromagnetic spectrum in relation to frequency, equivalent wavelength,
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equivalent frequency for electroporation pulse length, and the electromagnetic
regimens as they pertain to numerical modeling, and imaging techniques used in
the frequency ranges. The color transition from red through violet in the wave
property bar represents the shift in frequencies in the visible range of the
electromagnetic spectrum. The left end of the bar represents the lower
frequencies that correspond to very long wavelengths. On the right side are
radiations with higher frequencies that are associated with shorter wavelengths.
For the entire spectrum, wavelength, λ (m), is inversely proportional to its
frequency, f (1/s), and directly proportional to the speed of light, c (3·108m/s in
vacuum).
Fourier transform of electroporation rectangular pulses in the time domain

Figure 4.1. Electromagnetic spectrum and electroporation pulse length.
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yield information about the electric field magnitude content in that corresponding
frequency domain [65]. Figure 4.2 indicates the equivalent frequency domain
magnitudes obtained by applying the Fourier transform to a rectangular pulse in
the time domain. Since most of the magnitude of the pulse is restrained to a
narrow frequency band, a convenient approximation is to use time-harmonic
approximations in that frequency range to account for the magnitude of the
electric field. Using such approximations, it is possible to represent regimens of
electric field mediating pulses in comparison with the electromagnetic spectrum
wave groups as highlighted by yellow arrows in Figure 4.1.
As suggested earlier, the wavelengths of the wave groups can be
compared to various objects. By comparing the size of an object or affected
tissue to the fundamental frequency of the applied electric pulse, it is possible to

Figure 4.2. Fourier transform of electroporation rectangular pulse.
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categorize the electromagnetic spectrum of the electric fields into three regions.
The first region is when the equivalent fundamental wavelength of the electric
pulse is much longer than the size of the affected tissue section. The second
region is when the wavelength and the size are similar, and lastly, when the
wavelength is much shorter than general volume dimensions of tissue affected
by the pulse’s electric field. In each case it is possible to use approximations to
model the electric fields as they pertain to electroporation applications.
4.3.1. Wavelength Longer than the Size of Affected Tissue
Theoretical

analysis

and

experimental

evidence

from

impedance

tomography investigations have led to approximations that can be employed
when the wavelength of the applied electric pulse is much longer than the tissue
section. In this case, the decoupling of the electric and magnetic fields can be
used to modify Maxwell equations. Specifically, Ampere’s Law (equation 4.6),
can be represented in its time harmonic and vectorial form [66]:
×H=-ሺσ+jωε0 εr ሻE

(4.6)

where x denotes the curl operator, H is the magnetic field vector, E is the
electric field vector, σ is the conductivity of the material (S/m), ε0 is the
permittivity of free space (8.8542..·10-12 F/m), εr is the relative permittivity of the
material, and ω is the angular frequency.

The decoupling of the electric and

magnetic fields makes the curl of the magnetic field 0 (equation 4.7):
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×H=0

(4.7)

The approximation of the decoupled electric and magnetic fields is
commonly known as the quasielectrostatic approximation. This approximation is
represented here as equation 4.8:
-ሺσ+jωε0 εr ሻE=0

(4.8)

where the terms in parenthesis on the left hand side of the equation is also called
the complex conductivity, or admittivity (κ) which is a descriptor for electric
characteristics of biological materials for longer wavelengths than the object [67]
(equation 4.9):
(4.9)

κ=σ+jωε0 εr

The simulation quasielectrostatic module of COMSOL Multiphysics uses a
form of equation 4.6 to solve problems involving electric fields in tissue systems
[61]. This approximation has also been used for various impedance tomography
applications [68-70]. Multi-frequency impedance tomography has validated such
an approach in a frequency range usually from 10 Hz, and up to 1 MHz [71].
Furthermore, impedance tomography has been successfully utilized to image the
changes in conductivity resulting in tissue affected by electroporation [72, 73].
4.3.2. Wavelengths Approximating the Size of Affected Tissue
The approximations used when wavelengths are longer than affected
tissue do not apply because electric and magnetic fields are highly coupled. For
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this case, it is more convenient to use wave theory because propagation effects
dominate, and the wave behavior of electromagnetic energy is more relevant in
this range. Phenomena such as resonance and oscillations are also relevant in
this range of frequencies [74]. Diffraction, reflection and refraction must also be
considered when modeling fields in this regimen.
4.3.3. Wavelength Shorter than Size of Affected Tissue
The case in which wavelength is much shorter than size of the affected
tissue is not considered in this work. There is no background work for the use of
such high frequency pulses in electric field mediated drug and gene delivery.
This range of frequencies includes wavelengths in the visible spectrum,
ultraviolet light, and x-ray and gamma rays. In this range of frequencies, ray
behavior of electromagnetic energy is considerably more relevant [74].

The

effects that occur at such frequencies cannot be considered within the domain of
electroporative pulses.
4.4. Objects in Electric Fields
The understanding of the application of electric fields to objects in a
isotropic media is an important initial step when developing models that study
electroporation in tissues. A very convenient analytical analogy to interaction of
electric fields and objects is that of irrotational fluid flow (Feynman, 1964) [75] or
potential flow (Batchelor, 2000) [76]. Irrotational flow refers to flow which lacks
vorticity. The photograph in Figure 4.3 shows the conduction of water molecules
around a rock [77].

In this image, it is possible to appreciate the water
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Figure 4.3. Flow of water around rocks [77]. Reproduced under the Creative
Commons License Attribution 2.0 Generic (author: the_tahoe_guy).
streamlines as it surrounds the rock, and how the flow deviates around the rock.
It is also possible to appreciate that far from the rock, the flow lines do not curve.
At such distances, the rocks lack influence on the flow. The image allows one to
visualize by analogy, how the electric field in a conductive medium behaves
around a non-conductive object such as the rock in the figure. Feynman [78]
describes such an analogy using irrotational flow which is much simpler than the
incompressible

Navier-Stokes

representation.

Feynman’s

develops

the

equations representing the electric fields analogy to irrotational flow for a sphere
under an applied field (see Figure 4.4), starting with the continuity equation for a
flow of constant density (equation 4.10), and Gauss’ law in a charge free medium
(equation 4.11) in the following way:
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·v=0

(4.10)

·E=0

(4.11)

where v (m/s) and E (V/m) are the velocity and electric field vectors respectively.
The irrotational-flow or “dry water” (equation 4.12) condition neglects the
viscosity, compressibility, and surface tension of the fluid. The “dry water” term
was coined by the mathematician John von Neumann and often used by
Feynman [75] to describe an idealized fluid lacking viscosity and not subjected to
vorticity effects. The electrical equivalent of equation 4.12 is shown in equation
4.13:
×v=0

(4.12)

×E=0

(4.13)

The gradient of the potential for flow ψ, (equation 4.14), and the electrical
equivalent (equation 4.15) are as follows:
v=-ψ

(4.14)

E=-V

(4.15)

where ψ is the velocity potential (in m2/s) and V is the electric potential (in volts or
J/C) Feynman then develops the equations for a spherical object within a fluid
potential or a electrical potential. The solutions for the potential at any given
point in relation to the center of the sphere under a field are as follows for both
the fluid (4.16), and the electrical equivalent (4.17):
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a3
ψ=-v0 cosθ ቆr+ 2 ቇ
2r
a3
V=-E0 cosθ ቆr+ 2 ቇ
2r

(4.16)

(4.17)

where the coordinates are expressed in terms of the angle θ and the distance r
from the center of the sphere, a is the radius of such sphere, and v0 (m/s) and E0
(volts/m) represent the nominal velocity and nominal applied electric field
respectively. Nominal values for fields are those that are not influenced by the

Figure 4.4. Flow of irrotational fluid around a sphere in a velocity field.

38

object. These values will be found at a distance greater than r which is several
multiples of the radius of the sphere, a. The depiction in Figure 4.4 shows the
sphere as positioned within a velocity field. The direction of the velocity field
stream lines represents the direction of the velocity or electric field. A direct
analytical analogy to electric fields is made from the velocity field analysis of such
model.
The analytical solution of the potential ψ presented in equation 4.17 can
be compared to the numerical solution approximation for ψ using the COMSOL

Figure 4.5. Comparison of the analytical and numerical solution for the electric
potential (V) around a sphere.
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Multiphysics based methods described earlier in this chapter (section 4.2). To
show the agreement between the two solutions, the radial distance has been
made to match that of the radius of the sphere r = a = 25·10-6 m, and E0 = 1 V/m.
Figure 4.5 shows the numerical solution (red line) and the analytical solution
(blue stars) provided by Feynman describing the potential around a spherical
object. The horizontal axis represents the angle in degrees (°), and the vertical
axis, the potential in volts (V). Numerical solutions built on the same COMSOL
platform are used throughout this dissertation to represent electric fields in tissue.
Table 4.1. Models for electroporation that describe induced potential drop at cell
membrane.
Description

Model

Sharing of equipotential in core of
cell,
potential
differential
at
maximum [18]

∆VM =1.5·a·E0

(4.18)

Introduces the radial position using
the angle θ, and the cell shape
factor, fs, the shape factor, can vary,
but becomes 1.5 for spherical cells
[79, 80].

∆VM =fs ·a·E0 ·cosθ

(4.19)

Contains the conductivity factor, fσ
which
takes
into
account
conductivities of the membrane,
media, and inside of the cell [81,
82].

∆VM =1.5·fσ ·a·E0 ·cosθ

(4.20)

Introduction of the time dependence
of cell permeabilization. Introduce
time resolution by the relationship
between pulse time t, and charging
time of the cell membrane, τ [83,
84]

∆VM =1.5·fr ·a·E0 ·cosθ· ൬1-e-τ ൰

t
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(4.21)

4.5. Cells in Electric Fields
The events leading to electroporation of cells deal with the direct and
indirect effects of electric fields on the cell membrane.

The literature on

electroporation that investigates direct effects of electrical impulses on cell
membranes predict electrical breakdown of cell membranes at a threshold of
induced transmembrane potential.

The models describing the induced

transmembrane potential have been compiled by Hickey in 2005 [85] and are
shown in Table 4.1. In all instances, the common component of the formulations
for

electrically

induced

membrane

breakdown

of

spherical

cells

by

electroporation is the term 1.5·a·E0 ·cosθ describing the potential across the cell
membrane.

This factor coincides with the case for which equation 4.17 is

simplified for a=r and which has been plotted using both analytical and numerical
methods in Figure 4.5. It is important to note that most of these models were
developed for cells in media, which usually was of higher conductivity than the
cell cytosol.
Electric impulses also produce mechanical forces on the cell membrane
due to the electrostrictive and electrodynamic nature of cells in tissues. These
forces have been the subject of a substantial amount of research [86]. Evidence
for such electromechanical force can be seen in extreme cases such as
electrocution lesions, in which nuclei of cells in the affected tissue cluster and
elongate in the direction of the applied field [87]. The electromechanical effect is
not exclusive to the cellular scale, but also manifests itself at the tissue scale;
even under applied electric fields similar to those used in electroporation [88].
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Another electrophysical phenomena that is important in electric field
mediated drug and gene delivery is the electrokinetic transport of particles.
Such transport is dependent on local electric field intensity and direction, and can
take the form of electrophoresis, dielectrophoresis, or electroosmotic flow, or a
combination of these phenomena. Such phenomena have been the focus of
study for small and large molecules in electroporation pulses. It is particularly
important in the case of electroporation of large molecules such as DNA. This
importance is evidenced by experiments in which labeled DNA was
electroporated into cells in suspension and imaged using rapid time lapse
photography. In these series of experiments, the labeled DNA was transported
to the surface of the cell membrane during the electroporative pulse, but, uptake
of the molecule to the nucleus was a separate process that had a much longer
duration. This implies that the DNA transport to the nucleus is a biologically
endogenous process to the cell [89, 90].
The interstitial transport of molecules resulting from applied electric fields
is also the subject of theoretical, empirical, and numerical modeling.

Hickey

2005 [85] built an analytical model of molecular transport of DNA in tissues
based on data acquired from electrophoretic gel experiments. In support for the
present dissertation, Rey et al (2010), modeled the electrokinetic facilitated
transport of DNA during an electroporative pulse, and showed the interstitial flow
and mass transport of DNA that resulted in increased concentrations of DNA at
the cell membrane [91]. Figure 4.6 shows the mass transport results for this cell
cluster model.

The figure indicates increased available DNA at the cell
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Figure 4.6. Available concentration of DNA at boundaries of cell membranes.
membranes on one side of the cells in the cluster. The availability of DNA in
mol/m3 is dramatically increased at the cell membrane portions that face in the
opposite direction to the applied electric field.

The concentration of DNA

available at the cell membrane in the case of this model was 10 times larger than
that of the initial concentration of DNA in the interstitial space. These numerical
results, in addition to the analytical models and the experimental results
mentioned above emphasize the significance of transport processes in
electroporation.
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4.6. Objects and Tissues in Electric Fields
The complexity of the phenomena occurring in tissue under the effects of
electric fields is non-linear, and dynamic in nature. Such effects are not limited to
occurring during the electroporation pulse duration, but can modify tissue for
periods of time that exceed that of the pulse. Figure 4.7 shows a representation
of a projection of a spherical object embedded in tissue. The hatched area
represents a portion of the tissue that has been subjected to high electric fields.

Figure 4.7. Conductivity changes due to electric fields.
The tissue response to electric fields is not linear in part because of the changes
in dielectric characteristics due to tissue permeabilization [92]. These changes
can be observed during and between applied pulses. The area subjected to the
highest electric field intensity (shown in Figure 4.7) is likely to experience
increased conductivity leading to modification of distribution of electric field
vectors in consecutive pulses.

This modification of tissues electrical

characteristics during and in between pulses has been the subject of several
studies [92-94].
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Figure 4.8. Modification of electric field path by nearby objects.
Furthermore, complexity also arises from the presence of adjacent objects
within a tissue section (Figure 4.8). The path of electric fields, and how they are
influenced by a particular object embedded in tissue will significantly vary due to
other adjacent objects. Electric fields are not only modified by the presence of
other foreign objects, but also by the composite electric characteristics of tissue,
or other types of tissues. Model analysis of this effect involving a very simple
case of two adjacent objects embedded in tissue is presented in Chapter 7.
The differences in dielectric characteristics, and compartmentalization
provided by the cellular membranes modifies electric fields in a manner that is
tissue and frequency dependent (Figure 4.9.a).

Electric fields may also be

modified for macroscopic aspects such as location of electrodes, asymmetry of
contacts due to geometry and local differences in tissue conductivity (Figure
4.9.b). These alterations in an electric field are represented in Figure 4.10 as
meandering red dashed streamlines.
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Figure 4.9. Modification of electric field path due to cells and macroscopic
asymmetries.
The increased local electric field intensity in the proximity of the
microspheres also gives rise to secondary events while the pulse is applied.
electroosmotic flow (represented in Figure 4.10 by curved arrows) can both
create local pressure gradients as well as drag forces in the proximity of
embedded objects, such as a microsphere [95]. Such flow, pressure gradient, or
force will depend on the characteristics of the surface of the material of the
microspheres, the ionic nature of the surrounding fluid, and the geometry of
interstitial space surrounding the microspheres. The electroosmotic flow can
manifest itself in the form of flow, pressure gradients, and a force exerted by the
microsphere on the matrix in which it resides [95].

Electroosmotic flow is

generated when electric fields produce a drag force on fluid around a charged
object. The flow velocities are proportional to the charge contained within the
electrical double layer (Debye layer).

46

Figure 4.10. Electroosmotic flow due to electric fields and charged surfaces.
The pressure gradients generated by electroosmotic flow around particles
in proximity turns the system into an electroosmotic pump [96]. Electroosmotic
flow

and

electrophoretic

facilitated

transport

might

be

responsible

for

accumulating higher concentration of charged drugs in certain regions such as
near the surface of the object (see Figure 4.11). This concentration of material

Figure 4.11. Concentration gradients due to electroosmotic flow.
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around the embedded object is analogous to that of the concentration of DNA
molecules at the cell membrane shown in Figure 4.6. Electrophoretic facilitated
transport generates forces that act directly on charged molecules such as DNA,
and is responsible for their transport in porous matrices such as gels and tissues
[85]. Another source of pressure values on the surrounding cells may arise from
polarization due to charge buildup in the surroundings of an embedded object.
As shown in Figure 4.12, dipole forces (red vertical arrow) are a function of the
electric field gradient and polarization, while dipole torque (curved dashed red
arrow) originates from electric fields that are orthogonal to the polarization [97].
The resulting mechanical forces and torque can facilitate the permeabilization of
cell membranes in the proximity of the embedded object.

Figure 4.12. Polarization induced forces and torque.
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Chapter 5. Summary Part I
The successful performance of the implantable glucose biosensor requires
reliable long term function in vivo. As suggested in the Prelude to Part I, the
dissertation research to address this challenge would be based on a strategy that
merges two technologies and leads to two exploration pathways. The strategy is
to modify the implant's tissue environment to enhance implant’s performance.
The two technologies, oxidation/reduction chemistry based biosensors and
electric field mediated agent delivery, actually dictate two tissue engineering
pathways for this strategy:
(a) Modify the surgical implantation procedure to include the corrective
agent that alters the tissue in the proximity to the implantation site. This
pathway will be referred as the preemptive approach.
(b) Modify the tissue in the proximity of the sensor sometime after the
sensor enters its operational phase. Hereafter referred as the reactive
approach.
Both preemptive and reactive pathways are visualized in Figure 5.1. The
figure is an enhanced version of the injury impact after implant illustration in
originally shown in Figure 2.3. Figure 5.1 indicates the timing for the two tissue
intervention options. For the surgical implantation procedure option, the tissue
modification at the implant site would begin at the blue arrow, and would have an
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influence (expression) profile similar to the blue curve in Figure 5.1, as the
implant begins its operation. For the second option, the tissue would be modified
after the impact of the fibrous encapsulation process, the green curve in the
figure represents the influence profile that is synchronized with the encapsulation
process.

Figure 5.1. Tissue reaction to implanted biosensor, and two potential tissue
modification strategies.
Although the strategic options are clear, their potential to really address
the performance challenge of a biosensor requires verification of fundamental
assumptions. These assumptions support the premise that the challenge to an
implant biosensor’s performance may be overcome. The literature and modeling
review presented in Part I combined with the wealth of information provided from
the corresponding references provide that assurance. The application of electric
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field for delivery of drugs and genes is a proven technology with protocols and
documented applications available as resources for this research. The redox
reactions, implant design, operational expectations for glucose implantable
biosensors are also well established. In addition, the literature provides evidence
that tissue engineering DNA based strategies can impact the sensor's life
expectancy and signal performance in vivo.
The final component needed for a successful research effort is the
resident expertise to support the effort. Again, the literature and modeling review
provided indicates the excellent juxtaposition of expertise in both technologies
resident at USF and represented in this research dissertation committee. Besides
the continuous injection of state-of-the-art ideas and best practices, the practical
execution of the experimental protocols summarized in chapter 3 were effectively
modified when needed to assure optimal use of research time and resources.
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Part II
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Chapter 6. Research Plan
The confidence that there is a basis for the research to be conducted
generates the need for a research plan to be developed and executed. This
research plan depends on a modeling exploratory approach prior to an
experimental heuristic attack. The plan is presented below as a series of
asynchronous steps. However, the steps are executed in a sequence that
highlights the milestones required to denote the overall progress of the work.
6.1. Development of Experimental Protocols
As suggested in the Summary of Part I, the development of experimental
protocols was facilitated by the in vivo animal protocol expertise resident within
the two research groups at USF. All of the experimental methods with their
specific details summarized in Chapter 3 were built on demonstrated techniques
used in electroporation and biosensor based investigations conducted at USF.
This literally represents experiments that involved hundreds of animals and
includes competent use of and analysis from appropriate instrumentation and
assay procedures. Modification of either protocol implementations or analysis
methods specific to this research will be noted when appropriate.
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6.2. Verification of Model Tools and Developed Mathematical Models
The essence of this dissertation effort is mathematical model driven. The
in vitro and in vivo experimentation was instigated to explore and/or confirm a
model expectation. Thus, a precursor model verification exercise involving the
software platform was essential. The COMSOL Multiphysics platform selected for
this research was tested with respect to the expected use of Maxwell type
formulations of partial differential equations. That verification exercise was
reviewed in Chapter 4 and the software's ability to support a partial differential
equation model with form and boundary conditions similar to specific models to
be developed in this research summarized in Figure 4.5. Experimental and
analytical verification for specific models developed for this dissertation will also
be performed and discussed relative to their respective research milestone.
These milestones are posted below as research questions which, when
answered, will define the totality of this dissertation.
6.3. Dissertation Milestone Requirements
The intended purpose of this work relies on the ability to answer the four
milestone questions presented below. This section indicates the chapter that
addresses the answers to each milestone question.

These questions guide the

model development and experiments presented in this work.
6.3.1. Is The Modeling Platform Adequate To Provide Results That Comply With
The Engineering Science Principle Under Investigation?

The answer to this

question was partially provided in Chapter 4 with the demonstration of each
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modeling element.

Chapter 7 presents further evidence to support this

milestone.
6.3.2. Can The Modeling Platform Support Further Complexity That Indicates
Physical Processes Related To Compartmentalization In The Tissue? This
milestone is addressed in Chapter 7 for a compartmentalized system. Section
4.5 provides an application to electrokinetic phenomena for a compartmentalized
cluster of cells.
6.3.3. How Do Conductivity And Permittivity Values Of A Target Tissue Impact
The Influence That Electric Fields Have On That Tissue?

This question is

addressed in Chapter 7. This chapter demonstrates electrostrictive phenomena
occurring as a consequence of conductivity and permittivity values for an applied
electric field of varying frequency.
6.3.4. Is It Possible To Use Model Representations To Determine In Vivo
Applications Of Electric Field Mediated Drug And Gene Delivery That Can Be
Adapted To Improve Implantable Biosensor Function As Per Summarized In
Chapter 5?

This question is addressed in Chapter 8 with the application of

electric field mediated gene delivery to modify the implantation surgical protocol
in a preemptive approach. Chapter 9 provides a novel electric field mediated
drug delivery application supporting a reactive approach.
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Chapter 7. Conductivity and Permittivity Impact on Electrostrictive Force Fields
With the confirmation of the COMSOL Multiphysics software platform as a
model construction tool for this research, milestone question 6.3.1, in addition to
the ability to model complex processes, milestone question 6.3.2., as provided in
Chapter 4, attention quickly shifts to modeling application to study and
understand the impact of conductivity and permittivity values on target tissue
exposed to an electric field, milestone question 6.3.3. The combined modeling
work by Lewis [98] on bilayer membrane electroporation and experimental
investigations by Dimova et al. [99-101] on the impact of electric fields on giant
vesicles indicate that electric fields generate a Maxwell stress resultant force that
mimics compression force normal to the target membrane. The creation of a
model with the resolution to delineate the roles of conductivity and permittivity
with respect to the impact of this stress force on tissues represents a first step to
understanding the effect of electric fields on tissues near a biosensor implant. In
addition, the ability to compare this new model’s predictions to the existing giant
vesicle experimental information contributes to the validity of a comport using the
model information relative to research milestone 6.3.3.
The basis for this model approach is the recognition that Maxwell stress
tensors can be used to render mechanical forces from the interaction of
differentially charged bodies to electric fields.
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The force acting on the cell

membrane can be expressed as the resultant of the stress tensors acting on the
cell membrane. Several models attempt to explain how the stresses influence
the cell membrane. By idealizing cell membrane as a compartamentalization
entity, the resulting stress on cell membranes can be generated from the
resultant of the internal (Tin) and external (Tout) Maxwell stress tensor TR
(equation 7.1) acting on the membrane [102].

Tin and Tout are calculated

following equation 7.2.
TR =Tin +Tout
Tj =-

(7.1)

E·D
I+E·DT
2

(7.2)

where E (V/m) is the electric field vector, and D (C/m2) electric flux density or
displacement vector as defined earlier in this chapter using equation 4.2; ε0 is the
permittivity of free space, and εr is the relative permittivity of the polarizable
material in the electric field.
Figure 7.1 shows a diagram of a differential area and an axial section of a
cell under such stresses. Figure 7.1(a) is a representation of the differential area
of cell membrane submitted to inside Tin and outside Tout tensor and
representative forces Fin and Fout. Figure 7.2 (b) is an axial representation of cell
membrane with tensor Tin and Tout resulting in TR.

A more complex model by

Lewis 2003 that uses similar methodology but that takes into account the internal
stresses and deformations generated within the lipid bilayer of the cell membrane
predicts a collapse at local electric fields between 7.1·107 and 2.3·107 V/m [98].
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Figure 7.1. Resultant Maxwell stress tensor on the cell membrane. From Rey
2009 [102]. Reproduction permission granted by IEEE.
Complete details and the results of this intensive modeling effort have
been published [102].

The model provided additional insight into membrane

deformations in terms of the compartmentalized dielectric properties, conductivity
and permittivity, values. A summary of these results is shown in Figure 7.2. Of
particular importance to this dissertation research was the confirmation that the
COMOLS Multiphysics model platform does support complex models for
predicting the cumulative effect that electrical properties of cells in tissue have on
a target tissue region that is affected by an electric field.
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Figure 7.2. Conductivity and permittivity influence in electrostriction forces. From
Rey 2009 [102]. Reproduction permission granted by IEEE.
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Figure 7.2a shows a superposition of modeling results for conductivity to
experimental results by Dimova el al. [99]. The model predicted results in the
graph contrast conductivity ratios (in the vertical axis) with frequencies; in
specific, the transition frequencies shown as dashed lines. The model predicted
this relationship for frequency values between 1Hz and 1GHz. For this specific
model, the predictions matched the experimental results that indicated that the
giant vesicle shape change in terms of the transition frequency (T1, and T2, in
Figure 7.2a) in which the vesicle changes shape. A particular transition range of
frequencies (T3 in Figure 7.2.a) was not predicted by the model. Yamamoto et
al. 2010 later indicated that the reason for this discrepancy might be in the
modeling of the boundary conditions for the cell membrane [103]. The model
included a prediction of the changes in permittivity values between the interior
and exterior of the giant vesicle.

These results in the form of transition

frequencies and predicted acting forces on vesicles are shown in Figure 7.2b.
The effort necessary to isolate permittivity values while keeping the conductivities
constant as provided in these results is a difficult task to achieve using the
experimental platform used by the Dimova and Yamamoto’s groups.
The model predictions represented in Figure 7.2 however are of particular
importance in electric field focusing.

This figure introduces the concept that

biological entities with an electric field applied are subject to have forces that
change considerably at transition frequencies. The material properties of objects
embedded in tissue can be selected depending on the available materials and
their dielectric properties. Figure 7.2a presents the case for conductivity while
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7.2b presents the case for relative permittivity.

In conclusion, the modeling

results provided in this chapter indicate a platform to analyze the effect of
compartmentalized

dielectric

characteristics

in

biological

systems,

and

strengthen the dissertation’s modeling platform as presented in milestone
questions 6.3.2, and 6.3.3. This paves the path to the realization of milestone
question 6.3.4 by validating the behavior of the electric field in complex biological
systems.
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Chapter 8. In Vivo Gene Electroporation for Implantable Glucose Biosensor
8.1. Introduction
The driving force for this research, milestone 6.3.4, is to investigate the
implementation of electroporation as a transport mechanism to improve the longterm function of an implantable glucose biosensor.

It is addressed with an

increased understanding of the dependence on dielectric properties of tissues in
frequency and the impact of electric fields on target cell membranes.

This

chapter presents electric field modeling and simulation work that supports the
design of an applicator and protocol, and their combined implementation to
effectively target the tissue of interest at the moment of implantation, as a
preemptive approach. Specifically, pulses of high electric field magnitude in the
proximity of the biosensor implantation site will allow localized transfection of
genes in surrounding cells.

A model that addresses the magnitude and

distribution of these electric fields is needed for this purpose. This study began
with the model assisted examination of applicator design options and culminated
with the in vivo testing of a selected design.
8.2. Applicator Design
Models were developed to generate juxtaposition of applicator and target
tissues. Three dimensional geometries were generated for these models. These
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Table 8.1. Electrical parameters used in numerical modeling.
Subdomain Group

Conductivity (σ, S/m)

Relative Permittivity (ε)

Electrodes

1.12e7

1

Tissue

0.5
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3D models were used to select the best electrode configuration, and then to
assess the magnitudes of the electric fields at the target tissues. The selection
process was intended to maximize the electric field exposure of the target tissues
while minimizing its impact on non-interest tissues.

The 3D models were

developed using the Generalized Electric Fields application mode in COMSOL
Multyphysics; as it allows utilization of both permittivity, and conductivity
properties of materials. The materials represented in the model were collected
into two groups that define the subdomains. The first, represented conductive
materials, and the second, represented the tissue of the animal where the
electric fields are to be applied.

The electrodes were modeled as inactive

domains and had boundaries that represented either a potential, or ground. The
COMSOL multiphysics subdomain assignments are shown in Table 8.1.
Table 8.2. Boundary conditions in 3D electrode system 3D models.
Boundary

Two surface electrodes

Cannula as electrode

Tissue – Surface Ground
Electrode

Surface electrode broken in
two: One is ground, the other
is at a Potential

Tissue – Cannula

Applied Potential

Continuity

Tissue – Air

Insulation

Insulation
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Boundary conditions were required to represent physical conditions at the
interface between subdomains. At the interface between electrodes and tissue,
the boundary conditions selected either describe an applied voltage, a ground
condition (V=0), or a continuity in the case of the cannula when it has no applied
field. Any outer boundary is represented as an inhibition to normal current flow.
Table 8.2 summarizes the boundary conditions for the applicator design models.
The finite element meshing for the models used 140,766 and 138,530
tetrahedral elements for the cannula electrode model and the two surface
electrode model, respectively. The number of elements represents a balance
between the minimal number of elements required to solve the equations and
limited computing power.

Both models were solved using the generalized

minimum residuals (GMRES) linear system solver and algebraic multigrid
conditioner [104]. Post-processing of data was used to calculate and analyze
electric field maps that generated estimations of the distribution of electric fields
at the electroporation region within the rat tissue.
Two electrode configurations (illustrated in Figure 8.1 and 8.2) were the
subject of model calculations. In the first model, depicted in Figure 8.1, two
surface electrodes (shown in blue) are used to apply electric fields at the site of
implantation.

In this design, the cannula (in green) only serves to insert the

implantable biosensor in the subcutaneous tissue while insulating the implantable
biosensor from the applied electroporation pulses. The cannula in this case is
not an active electrical component. The simplified 3D shape of the targeted
tissue is shown in gray.
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Figure 8.1. Two surface electrode model.
In the second electrode configuration, shown in Figure 8.2, the cannula (in
green) used to insert the biosensor serves as an electrode used in the
electroporation process. The counter electrode is a surface electrode on the skin
of the animal (in blue), covering the area on the surface of the implantation site.
Again, the simplified 3D shape of the targeted tissue is shown in gray. The
implantable biosensor can be inserted after or before the pulses are applied, as
long as the sensing element is positioned at the required electroporation site.
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Figure 8.2. Cannula and single surface electrode model.
The two electrode configurations were evaluated using a nominal applied
electric field of 1,250 V/cm. The model predictions of electric field distribution for
both electrode configurations are shown in Figure 8.3. This information provides
insight as to which electrode configuration option best matches the biosensor
surgical implantation protocols and provides the most favorable electric field
distribution in the volume surrounding the implantation site. The configuration
with the two surface electrodes (Figure 8.3a) had field intensity in excess of
5,600 V/cm at the electrode-skin interface and an average electric field intensity
of 1,400 V/cm within 0.5mm of the cannula.

The electrode configuration that

uses the cannula as an electrode had maximum electric field intensity of 2,500
V/cm at the electrode-surface interface and an average electric field intensity of
2,000 V/cm within 0.5mm of the cannula.

By this measure, the electrode

configuration using the cannula as an electrode provided a reduction of electric
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field intensity of 56% at the skin-electrode interface, while provided an average
electric field intensity in the immediacy of the implantation site that is 43% higher
than that of the two surface electrodes.

Figure 8.3. Cut plane of the electric field map from a 3D simulation of the
electroporation applicator for both cases.
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Figure 8.4. Electric field intensities from post-processing output of finite element
analysis model.
Figure 8.4 indicates the cannula applicator model from a 3D perspective.
The results also provided information about field distributions along the cannula
and was used to ensure that such field intensities were kept within the confines
of the implantation site. The 2D representations in 8.3 are a cut through the mid
section of the surface electrode.
8.3. Protocol Development
The delivery protocol developed is summarized in section 3.1.1. The in
vivo imaging analysis provided useful information in the determination of effective
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electroporation parameters, and time (in days) for maximum expression. The
totality of the expression results from the IVIS imaging system on control and
experiment animals are presented in Figure 8.5. From this data, the effective
magnitude of the electric field can be estimated between 1,250 and 1,750 V/cm
(Figure 8.5) with a maximum expression between 8 and 15 days (Figure 8.6).

Figure 8.5. Bioluminescent results for rats in groups for days 0, 1, 4, 8, 15, and
22.
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The results from bioluminescence expression are provided graphically in
Figure 8.6.

The graph’s vertical axis is photon flux (photons/sec/cm2), the

horizontal axis is in days (0, 1, 5, 8, 15, 22). The plotted lines represent selected
experiments electric fields in axis (E = electroporation only control, L = Luciferase
only, L+E1 = 750 V/cm electroporation, L+E2 = 1,250 V/cm, L+E3 = 1,750 V/cm.
Points with a star (*) represent results which are statistically significant (p<0.05)
from the control.
The in vivo delivery of reporter genes provided the necessary information
to select a single electroporation parameter and improve the technique to
effectively deliver genes in the subcutaneous tissue. For the in vivo delivery of
future neovascularization factors coding plasmids, a single electroporation
parameter was chosen as 1,250 V/cm, 150μs, and 4 pulses separated by 1 a
second delay. The same concentration of 2 mg/ml of plasmid in saline solution
was used and two different volumes were tested, 50 μL and 100 μL. Using the
information gathered from the previous study the plasmid injection technique, a
very critical step of the protocol, was improved in order to ensure that the plasmid
solution is at the targeted subcutaneous site before the electric field that supports
electroporation was applied.
Regarding other studies that use electroporation protocols in cutaneous
tissue, Colman et al. 2004, reports maximum Luciferase activity at 14 days post
electroporation in cutaneous wound border (intradermal). In this study, 50μL of 2
mg/ml (100 μg) gWiz plasmid was used and different parameters were tested to
find the most effective protocol [105]. A later study (Lin et al., 2006) found that
70

luciferace expression resulting from intradermal injection was 63-fold higher than
that for subcutaneous injections. However, the pin electrode used in both of
these studies was designed for intradermal and not subcutaneous delivery of
plasmids [106]. In the case of the cannula and surface electrode configuration
used in this chapter, the electrode was used for subcutaneous electroporation.

Figure 8.6. Selected electroporation parameters and progression in time of gene
expression.
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The modeling and experimental results from this chapter provide
information needed to improve the electroporation protocol, select electroporation
parameters, and estimate the expression chronological profile for plasmid DNA
for subcutaneous tissue in rats.

This information allows the estimation of the

timing at which neovascularization factor expression occurs, as long as its
expression profile is similar to that of the Luciferase plasmid used here. This
chapter provides a protocol to deliver plasmid DNA to the site of an implantable
biosensor at the time of implantation, in fulfillment of the preemptive approach as
presented in Chapter 5 and milestone 6.3.4.
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Chapter 9. Focusing of Electric Fields for Electroporation
9.1. Introduction
The distribution of the electric field intensity generated for electric field
mediated therapeutic agent delivery is dependent upon many factors including
electrode geometries, electrical characteristics of tissue, and electric pulse
parameters. A typical electrode configuration used for electroporation purposes
has higher electric field intensity closer to the electrodes; this creates electric
field gradients that produce regions with different cell permeability [4]. As the
models presented in Chapter 8 suggest, electrode configuration greatly impacts
the location and distribution of such regions.
The impact the electric field has on cells inevitably depends on the
magnitude of the applied potential between the electrodes.

As discussed in

section 4.1, the application of pulses might result in areas with higher electric
field intensity where some cells die due to irreversible permeability, increased
Joule heating, or local electrochemical effects. In electric field mediated drug
and gene delivery, the objective is to maximize the regions with appropriate
electric field intensity defined between regions with irreversible electroporation
and no resulting cell permeability.
The ability to focus electric field intensities at target regions should provide
a means to deliver the appropriate electric field intensity to a target site while
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reducing the required applied nominal electric field. A lower applied nominal field
should result in reduced localized adverse effects at the electrode-tissue
interface. Electric field focusing is a phenomenon that results from the insertion
of an object in the path of an electric field in an otherwise isotropic media. As
suggested in section 4.4, an object with electrical characteristics sufficiently
different than those of the media will induce localized zones of high and low
electric field magnitudes in its vicinity. Figure 9.1 demonstrates this phenomenon
as part of an in vitro feasibility study that has been published with the
experimental details provided in section 3.2.1 [107].

Figure 9.1. Image compositions from an electric field focusing feasibility study.
The figure shows electric field focusing in a 2-dimensional dish. The
nominal field strength did not produce significant calcein uptake (Figure 9.1a).
However, as is visibly evident in Figure 9.1b, the case with the field focusing
element (four rectangles arranged in an “X” shape) caused amplification above a
threshold that allowed increased uptake of the fluorescent dye.
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This

phenomenon has also been used in vitro by Golan et al.

in a microfluidics

application to transport cells using dielectrophoretic forces resulting from electric
fields focused by floating electrodes.

In this dielectrophoresis application,

erythrocytes accumulated on the surface of the floating electrodes by following
the gradient towards higher electric field intensity [108, 109].
9.2. Electric Field Focusing Model Predictions
The clear evidence of field focusing presented in Figure 9.1 generates the
rational to develop a model to study the phenomena, as well as two additional
concepts developed in the course of this dissertation which indicate the
complexity of the assignment. The first consideration, as discussed in Section
4.3 is the fact that the energy associated with an electroporation pulse can be
analyzed based on its frequency components.

The second consideration

materializes from the exploration of milestone question 6.3.3. As indicated in
Chapter 7, the model prediction confirmed independent experimental evidence
that conductivity and permittivity also influence the effect of an applied field as
the frequency components of such field are swept across the frequency
spectrum. Thus, a viable model that will predict the local electric field intensity
due to the field focusing effect of an object in the field must include pulse
frequency in conjunction with exposed media conductivity and permittivity.
Because of the predominantly low frequency content of the pulsed electric
fields used for in vivo electroporation applications, and the dielectric nature of
tissues, the assumptions in section 4.3.1 apply.
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Under such conditions,

conductivity and permittivity are the parameters of biological materials commonly
used to describe applied electromagnetic phenomena [110]. To represent the
effects of electric field focusing at the scale of the implant, COMSOL
Multiphysics’ axial symmetry and three-dimensional geometric descriptions of
features were utilized.
With the purpose of comparatively representing how electric fields are
focused by microspheres used in the experimental section of this chapter,
electric field intensity (E) in the model was divided by the applied nominal electric
field (V0/d). V0 corresponds to the applied voltage, and d to the distance between
the parallel plates used to apply the potential across the tissue section in the
model.

The resulting ratio (E*) is the non-dimensional electric field intensity

which is presented in equation 9.1. In the absence of microspheres, the nondimensional field intensity values are evenly distributed in the geometric volume.
In the presence of microspheres, these intensity values vary as they are focused
in specific regions of the geometry.
E* =

E
V0 /d

(9.1)

Modeling results show that polystyrene microspheres embedded in tissue
exposed to an electric field generate focusing of the field that is related to
geometric variables and material characteristics of the microspheres and tissue.
The two principal material characteristics used in the models are conductivity and
relative permittivity. They are both significant in focusing electric fields, however,
their significance is dependent on the frequency of the applied electric field; this
frequency dependence will be discussed later in this chapter.
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Figure 9.2. Representation of electric fields as they are modified by spheres in
the media.
Figure 9.2 is a collection of visual depictions of the electric field focusing
phenomena and how the contrast in dielectric characteristics (conductivity and
permittivity) of the microspheres and the surrounding media creates gradients of
the electric field in the media. Figure 9.2a is a 3D representation of tissue with
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multiple microspheres.

Figures 9.2b, 9.2c, and 9.2d show three different cases

in a simplified view of a slice of electric field intensities in a plane on the upper
spheres in 3D representation in 9.2a. Figure 9.2b. represents the case in which
microspheres have the same dielectric properties as tissue; in this case, the field
is not focused, thus the non-dimensional electric field intensity value is 1
throughout the volume.

In the case where either the conductivity or the

permittivity are lower than the tissue (Figure 9.2c), the focusing effect generates
higher electric field intensities in the vicinity of the microspheres that arranged
transversally to the direction of the applied field. The direction of the electric field
vectors on the plane (white arrows) are approximately tangential to the surface of
the microspheres. This case is similar to that of analogous flow of fluid around
an obstacle presented in Figure 4.3.

Alternatively, the case in which

microspheres have either higher conductivity, or higher relative permittivity than
the media (Figure 9.2d), the higher intensities of the electric field focus parallel to
the direction of the applied field. In this case, the direction of the electric field
vectors (white arrows) on the plane steer normal to the surface of the
microspheres.
Figures 9.2e and 9.2f show pseudocoloring depicting electric field focusing
around single spheres which have an electric field applied in the direction of the
large arrow pointing down.

Figure 9.2e shows the case in which either

conductivity or relative permittivity are lower than that of the surrounding media;
white streamlines represent electric field lines around the spheres.

The

analytical solution to the case presented in Figure 9.2e is presented by Cole et
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al. 1964 and is presented section 4.4 of this work as well [111]. Figure 9.2f
presents the case in which the conductivity or relative permittivity of that sphere
is considerably higher than the surrounding media. The way in which electric
field intensity is focused depends on how marked the contrast of dielectric
characteristics are from the microsphere to the media.

In the case of this

example, the microsphere being a perfect conductor, and the media a material of
very low conductivity, the electric field streamlines become close to normal to the
surface of the microsphere.
Although the experimental portion of this work is limited to using
polystyrene microspheres, it is possible to estimate by way of numerical
modeling the potential electric field focusing effect that different materials may
have if they are embedded in tissue.

Figure 9.3 shows analysis of non-

dimensional electric field maxima for several material cases in Table 9.1. Figure
9.3a uses pseudocoloring to present higher magnitude electric fields focused in
the longitudinal direction (represented in red and the letter ‘L’) with respect to the
microsphere, and focused in the transversal direction (represented in red and the
letter ‘T’) with respect to the microsphere.

Non dimensional electric field

intensities for polystyrene microspheres which are used in the experimental
section of this chapter are presented in Figure 9.3b.

Polystyrene has lower

conductivity (1.0·10-16 vs. 1 S/m for tissue) and lower permittivity (4 vs. 65 for
tissue) when compared to tissue. The blue line in Figure 9.3b represents the
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field focused in the transversal direction to the direction of the applied electric
field.

In the low and high frequency regions (horizontal axis), the non-

Figure 9.3. Microsphere subjected to electric field 1 V/cm, and electric field
intensity behavior depending on material and frequency.
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dimensional electric field in the tissue is increased by a factor of about 1.5X
(vertical axis).
Figure 9.3c presents the case of an idealized material that has higher
conductivity (4.5·107 vs. 1 S/m), but the same permittivity as tissue. In this case,
the electric fields are focused in the longitudinal direction by a factor of about 3X,
represented by the red line. This idealized higher conductivity material has a
focusing factor that is restricted to the lower portion of frequencies; the frequency
about which the transition occurs is here defined as the transition frequency, and
represented in Table 9.1 as fT. The transition frequency for this idealized high
conductivity and same permittivity material is about 1·1016 Hz. The focusing
effect of the difference in conductivity is only in effect under this transition
frequency. Thus, the difference in conductivity between the microsphere and the
tissue has a focusing effect only under this transition frequency.
Figure 9.3d presents the case of an idealized material that has higher
relative permittivity (2.0·103 vs. 65), but the same conductivity as tissue. In this
case, the electric field intensities are focused in the longitudinal direction by a
factor of about 2.4X, represented by the red line.

This idealized higher

permittivity material has a focusing effect that is restricted to the higher portion of
frequencies above the transition frequency of 2·107. The transition frequency for
the idealized high conductivity material (in Figure 9.3c) is considerably high, well
above frequency components of electroporation pulses and the approximations
used for this model. In contrast, the transition frequency for the idealized high
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permittivity material (in Figure 9.3d) of 2·107 Hz is well within the range of
frequencies considered in the approximations presented in section 4.3.1.
Table 9.1. Microspheres of different materials and their potential electric field
focusing effect.
εr

Material

σ
(S/m)

E* max.
(l.f)

E* max.
(h.f.)

fT
(Hz)

Polystyrene [112]

1.0·10-16

2.6

1.49

1.47

~ 2·108

Conductivity and
Permittivity are same as
tumor tissue [113]

1.0

65.0

1.00

1.00

-

Conductivity different than
tissue

4.5·107

65.0

3.00

1.00

~ 1·1016

Permittivity different than
tissue

1.0

2.0·103

1.00

2.57

~ 2·107

Gold [112]

4.5·107

1.0

3.00

1.44

~ 1·1016

Barium Titanate (BaTiO3)
[114]

1.0·10-10

2.0·103

1.49

2.57

~ 2·107

Figures 9.3f and 9.3g represent the case of gold (Au) and barium titanate
(BaTiO3) respectively. In both cases, there is electric field focusing arranged in
one direction, which reverses at the transition frequency. The case of the gold
presented in Figure 9.3f is similar to the idealized high conductivity material
model, with the addition of the reversal in focusing effect. In the case of gold,
electric field intensities are focused by a factor 3X at lower frequencies in the
longitudinal direction (red line), and are focused at 1.5X at higher frequencies,
but in the transversal direction (blue line). Barium titanate, a ceramic with high
relative permittivity, presents a case in which the electric field focusing is higher
at high frequencies (~2.6X) than at low frequencies (~1.5X); the longitudinal and
transversal focusing of fields is inverse to that of gold.
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The cases presented in figures 9.3f and 9.3g are of particular interest
because of the reversal of the direction of the focusing effect (from longitudinal to
transversal, or transversal to longitudinal directions) as frequency changes from
low to high.

Figure 9.4 presents a three dimensional representation of electric

field focusing for a microsphere of a material similar to barium titanate, which has
lower conductivity, but higher relative permittivity than tissue. Figures 9.4a and
9.4b correspond to the frequency range below the transition frequency, and
figures 9.4c, and 9.4d represent frequencies above this value. The focusing
effect is represented by a volume enclosing the non-dimensional electric field
intensity higher than 1.1 with a red surface (figures 9.4b, and 9.4d). Focusing in
the transversal direction has a “toroid” like shape (Figure 9.4b), while the
focusing in the longitudinal direction has an hourglass or dual spheroid shape
(Figure 9.4d). This is for the case of a spherical object in the electric field; other
geometries will focus the electric field in different ways. Note that the streamlines
at lower frequencies are almost tangential to the surface of the microsphere
(Figure 9.4a), streamlines at higher frequencies tend to become normal to the
surface of the microsphere (Figure 9.4c). This frequency dependant transition
effect in electric field focusing brings an opportunity of focusing electric fields that
will be briefly discussed in Chapter 9.
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Figure 9.4. 3D rendering of electric field focusing on a single microsphere.
As briefly presented in section 4.6, the focusing effect of a single
microsphere is modified when more microspheres are in close range.

The

simplest example of the effect of multiple spheres is that of two spheres within an
electric field. The results from such a numerical model are depicted in Figure
9.5. As two microspheres are brought closer together, the focusing of the electric
field intensity between them is amplified.

Figure 9.5a shows a graph of the

numerical results of two microspheres approaching.

The horizontal axis

represents the cross section distance to the edge of each sphere. Figure 9.5b
shows two spheres separated, and pseudocoloring of the non-dimensional
electric field. In Figure 9.4a, the vertical axis represents the non-dimensional
electric field between the two spheres. The dark green U shaped curve at the
bottom of the 9.4a is that of two spheres separated by a distance equivalent to 2
diameters (2φ); in this case, the focusing factor has a high value of 1.5X at the
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Figure 9.5. Numerical results of electric field focusing due to two microspheres.
surface of the microsphere that drops to 1X (no focusing) at the center point in
between the two spheres.

The other case in which the separation between

microspheres is 1/16 diameters (light green line shaped as a small v) at the top
of the graph has a high value of 2.05X and a low value of 1.95X. These results
show that as spheres are closer together, there is a magnification of the focusing
effect. The presence of more than two spheres, or groups of spheres has the
potential to further increases the magnification shown in Figure 9.5.
9.3. Electric Field Focusing Model Experimental Verification
9.3.1. In Vitro Electric Field Focusing Model Verification
As an initial test for the electric field focusing model, the first assignment
was to produce a modelled electric field intensity view of the experimental results
shown in Figure 9.1b. For visual comparison convenience, these results are
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shown in Figure 9.6b. Various model verification perspectives are also provided
in the figure.
The control experiments equivalent to the geometries in the control
simulation (Figure 9.6b) did not exhibit calcein fluorescence in the center of the
cell culture dish. The actual control experiments shown in Figure 9.1a did not use
the rectangular elements, described in Figure 3.5, at the center of the dish.
Results

from

control

experiments

only

showed

fluorescence

due

to

electroporation only at the electrodes. This is another indication that the electric

Figure 9.6. Results from in Silico models and in Vitro experiment. Reproduced
with permission from IEEE.
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field mediation effect that promotes electroporation was present concentrated at
the electrode. However, the inserted rectangular objects altered the electric field
intensity in proximity of such objects and promoted electroporation at the center
of the dish.
The experiments that included the rectangular focusing elements in the
center of the dish (Figure 9.6d) produced a picture similar to those projected by
computer simulation that included these elements (Figure 9.6a); that is, the
presence of the non-grounded rectangular stainless steel geometries in the
center of the dish redistributed the electric fields and created a focusing effect
that raised the electric field above the threshold for electroporation and resulting
transport of calcein inside the cells in the dish. The threshold was defined as 600
V/cm for the system in the simulation, and is shown in Figure 9.6c as a horizontal
dashed line.

Figure 9.6c is cross section graph that depicts the values (vertical

axis) of electric field intensities across the dish. The green line in Figure 9.6c
represents the electric field intensities for the case of Figure 9.6a (focusing
experiment), and the red line represents those of Figure 9.6b (control). The
mentioned field focusing effect produced adequate electric field mediated calcein
delivery to demonstrate effective EP at the center of the cell culture dish in the in
vitro experiments (Figure 9.6d). Furthermore, for the rectangular elements when
compared to the control (Figure 9.5b), the simulations show that the redistribution
of electric fields lowered the electric field magnitude peaks near the electrodes.
This will provide the additional benefit of reducing possible field related cell and
tissue damage generated by the activated electrodes.
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9.3.2. In Vivo Electric Field Focusing Model Confirmation
Fluorescent imaging analysis of dye electroporation experiments provided
qualitative and quantitative information on microsphere distribution and dye
uptake that coincides with electric field focusing expectation. SYTOX® green is
a nucleic acid stain that will stain cell nuclei of both reversibly electroporated and
irreversibly electroporated cells.

Figure 9.7 shows an image at two different

scales of such results. Figure 9.7a shows about a fourth section of a tumor with
the periphery of the tumor delineated by a darker region on the left, and bottom
of Figure 9.7a. Figure 9.7b shows a magnified section (red square) of Figure
9.7a.

The green pseudocoloring superimposed on the optical image (in gray)

shows nuclei that have higher fluorescence due to Sytox® Green dye that
penetrated the cell nucleus and stained the DNA.

Figure 9.7. Microscopic view of Sytox Green uptake in melanoma tumor cells.
Bars with length in m show scale.
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Visual analysis of lower resolution (3 mm field of view) fluorescent and
optical composite images of tumors such as shown in Figure 9.7a provided a
qualitative distribution of microspheres.

In most images analyzed, it was

observed that microspheres tended to concentrate in the periphery of the
melanoma tumor. Analysis of higher resolution fluorescent images such as that
shown in Figure 9.7b provided visual information about distribution of
fluorescence intensity.

Figure 9.8. Optical and fluorescent images of microspheres in tissue section.
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Figure 9.8 provides additional images from the fluorescent dye
experiment. Figures 9.8a and 9.8c show optical images of the microspheres.
Figures 9.8b and 9.8d are fluorescent images of stained nuclei corresponding to
9.8a and 9.8c. The white arrows are provided as a visual queue for aligning
these images.
The intensity of florescence in cell nuclei had an apparent decay with
respect to the distance from the surface of the microsphere.

This decay in

fluorescence in relationship to distance was recorded and presented in Figure
9.9. The relationship between peak fluorescence in cell nuclei and maximum
electric field calculated radially from the edge of a 25 m microsphere in tissue is
shown in Figure 9.9. The near exponential decay of the fluorescence and the
electric field can be related by a logistic function to the decay in maximum
electric field intensity calculated numerically and starting from the edge of the
microsphere. This relationship takes the form presented in equation 9.2:
fN =1-

1

(9.2)
* p

E
1+ ቆ ቇ
E0

where fN is the measured fluorescence which is a function of the membrane
permeability Pm. This relates to the normalized electric field E* with the logistic
function with constants E0 taking a value of 1.03528, and p with a value of
31.87197. The R2 statistic value for this correlation is 0.68. Logistic functions
such as the one used to relate the fluorescence to the normalized electric field
are commonly used in the field of electroporation to relate conductivity changes
to applied electric field intensities in pulses [92-94]. Changes in conductivity and
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total impedance have also been used in the field to describe cell membrane
permeability and thus likelihood of intracellular drug delivery. Figure 9.9 is a
graphic showing the relationship between peak fluorescence in nuclei, and
electric field focusing factor in relationship to distance from edge of
microspheres. The red ‘x’ in the graph pertain to normalized measured values at
nuclei, the blue line is the maximum electric field in relation to the non
dimensional electric field, and the red dashed line represents the correlated
fluorescence as a function of electric field intensity.

Figure 9.9. Relationship between peak fluorescence in nuclei, and electric field
focusing factor in relationship to distance from edge of microspheres.
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9.3.3 Electric Field Focusing In Vivo Application
This experimental protocol was conducted as a demonstration of electric
field focusing in an electrochemotherapy application.

An electroporation

protocol was modified to include polystyrene microspheres.

Both survival

analysis and tumor volume data provided complementary information to the
results presented in Section 9.3.2.
In both cases, the group utilizing the microspheres, bleomycin, and
applied electroporation pulses showed significant improvement over classical
experimental conditions.

Survival analysis using a Logrank test

[115]

determined that only bleomycin plus electroporation increased survival
significantly from control, also, bleomycin plus electroporation group had a

Figure 9.10. Survival per groups as a percentage of initial group size.
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significantly higher survival (p<0.05) than control and bleomcyin, and the group
that received microspheres in addition to bleomycin and electroporation had also
significantly higher survival than control, bleomycin, and bleomycin plus
electroporation. Survival for all experimental groups is shown in Figure 9.10.
Tumor volume presented in Figure 9.11 is the average volume per group
with the condition that n2. The control was a simple injection of saline (solid line
with circles). The bleomycin injection and electroporation (solid line with
triangles) group had significantly slower tumor growth (p<0.05) than control. The
group that included the microspheres in the chemotherapeutic solution had a
significantly slower tumor growth than the control, and than that of the bleomycin
plus electroporation group until day 21. The apparent decay of tumor growth in
advanced dates is due to mice with larger tumors dying or being euthanatized

Figure 9.11. Tumor volume as a percentage of initial volume.

93

due to protocol maximum tumor volume. The reduction in tumor growth and the
survival improvement for the group that received the chemotherapy agent
containing the microspheres represents a significant improvement to all other
groups. The control group that contained microspheres in addition to bleomycin
did not show a significant improvement with respect to the group that received
bleomycin alone.

This shows that for this case, the introduction of the

microspheres did not improve the delivery of chemotherapy agent in the absence
of applied electric fields.
9.4. Discussion
The use of the focused electric fields for therapeutic molecule delivery
applications is advantageous as a desired effect can be accomplished remotely
from the electrodes. The application of the underlying phenomena to electric
field mediated molecular delivery can allow the application of lower intensity
electric pulses to achieve a similar result at the desired location. The protocol
used not only enhanced molecular delivery, but also survival in the case
melanoma tumor bearing mice.
The mechanisms for this increased uptake of drugs in the proximity of the
microspheres can be correlated to the local electric field intensity generated by
field focusing.

However, the same local electric field intensity values can

generate secondary mechanisms that produce a cumulative effect in the
permeabilization of cell membranes and enhancement of delivery.

Such

secondary mechanisms have the potential to increase or decrease the
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effectiveness of the electroporation pulse. The field intensity may be modified in
at least three different ways as explained in Section 4.6. First, the change in
dielectric properties of tissue during the application of the electroporation pulse
as presented in Figure 4.7, modifies the distribution of electric field intensities.
Second, as depicted in Figure 4.7 and summarized in Figure 9.5, the cumulative
effect of other microspheres modifies that of a single microsphere. Third, the
compartmentalized nature of tissues and macroscopic aspects as depicted in
Figure 4.9 modify electric field intensities in addition to the focusing effect.
Other secondary phenomena result in mechanical forces and flows that
can increase the electroporative effect of the local electric field. These include
electroosmotic flow that creates pressure gradients as represented in Figure
4.10. A result of the electroosmotic flow is varying concentration gradients as
shown for a spherical object in Figure 4.11 and a cluster of cells in Figure 4.6.
Finally, the charged nature of the polystyrene microspheres subjects them to
torque and forces (Figure 4.12) that translates as reaction pressures on the
adjacent tissue.
The application of this technology could be extended to use of smaller
particles such as nanoparticles, or can be scaled to larger objects such as
implants. In the case of nanoparticles, these could be targeted to specific tissue
regions by means of antibodies or other tagging mechanisms, and then used to
focus the applied electric field once they have accumulated at the desired
biological target.

Nanoparticles of different dielectric characteristics can be

combined to enhance the electrical contrast needed to focus the applied electric
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field.

There is the possibility that in the process of the injection of the

microspheres, the accompanying pressure on surrounding cells can lead to more
permeable cell membranes. Although the increase in pressure in absence of the
application of electric fields is a possibility, the results of the ECT experiment
indicate that improvement in delivery necessitates the presence of the electric
field focusing phenomena.
Applications to implants present an opportunity to combine materials with
contrasting dielectric characteristics and composite geometries. The effect on
local electric field intensities by composite materials such as Janus particles
could be of particular interest for electric field focusing [116, 117]. The focused
electric field intensities near an implantable biosensor can be used for
therapeutic molecule delivery, or used for strategies using secondary effects
such as electroosmosis and electrophoresis. The application of this work is also
suitable to other electric field mediated technologies such as ultra short pulse
(nanosecond) electroporation, which has been developed with remote delivery in
mind. The results presented in this chapter also provide an elegant solution to
the execution of the reactive approach as summarized in Chapter 5, and
milestone 6.4.4.

If the targeted tissue site in the proximity of the implanted

biosensor is to be instigated after the sensor performance decays, the approach
would be to apply a nominal electric field that produces the electroporation
conditions necessary to mediate the delivery of the required plasmid. Electric
field focusing provides the basis to attain these intended results.
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Chapter 10. Conclusions
This dissertation explored two basic approaches to blending electric field
mediated drug and gene delivery with the improvement operation of implantable
biosensors.

An exploratory approach was adopted to ensure that the new

modeling tools have a bioengineering basis to assure the merit of the
researched, pursued, and presented results. The dissertation built on the basic
demonstrated premise of electric field mediated drug and gene delivery,
electroporation, to create mathematical constructs that model the impact that
electric fields have on target tissue. These models were validated with analytical
and experimental tests and the execution of the task lead to new knowledge
pertaining to electromechanical forces present in tissues under the influence of
an electric field, and applications of electric fields to optimize agent delivery to a
target tissue as well as the modeling of DNA transport in the interstitial space.
The electromechanical forces model represents a modeling tool that
successfully uses material parameters, conductivity, and permittivity, combined
with electric field frequency components to accurately predict what would happen
to the shape of the biological target exposed to the electric field. This new tool
has immediate value in the exploration of electric field effects on complex
biological systems that have inherently compartmentalized values of conductivity
and permittivity. The cell cluster modeling tool used in DNA transport and the
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vesicle electromechanical model representative tools that researchers may
employ to analyze effects of an applied electric field on compartmentalized
systems.
The

electroporation

applicator

design

model

set

is

a

flexible

implementation that guides researchers to effectively develop applicator
geometries with expected electric field intensity gradient predictions prior to
prototype construction.

A design approach that provides a rational for using

electric field intensity values minimizes in vivo prototype applicator performance
studies and optimizes the impact of the expected electroporation within the target
tissue. A fundamental contribution that meets the goals of the project, effectively
modifies current subcutaneous implantation procedure to accommodate the use
of electric field mediated gene delivery.

It provides important information

regarding the expression profile of genetic material delivered by in vivo
electroporation.

This approach provides a palpable path to a preemptive

approach to improving the long term function of the glucose implantable
biosensor.
The development of electric field focusing meets project goals and opens
a new set of possibilities regarding its development as a viable method to
improve electric field mediated delivery of drug and genes.

The use of this

method provides an alternative to delivering necessary electric field intensity to
tissues in the proximity of the subcutaneous biosensor post implantation. This
approach, if used with proper neovascularization factors constitutes a responsive
approach to solving the fibrous encapsulation problem. The new electric field
98

focusing platform was presented from a theoretical perspective, and was
confirmed both in vitro and in vivo.

The use of electric field focusing was

extended to an electrochemotherapy application that proved in a very elegant
manner the feasibility to apply the concepts of electric field focusing.

The

“Recommended Applications” chapter (Chapter 11) provides a brief explanation
of the possible applications that project the use of electric field focusing to solve
problems where electroporation may play an important role.
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Chapter 11. Recommended Applications
The theoretical development and experimental verification of electric field
focusing opened a myriad of potential applications of the technology, as well as
new strategies for improving the state of the art. The application of the principles
outlined in Chapter 9 can be directly translated into tangible applications.
Applications include improvements to current technology such as needle
electrodes, and modifications to implantable device protocols to include the
technology.

Electric field focusing creates the rationale to allow the use of

electroporation in combination with biomedical applications that have never been
used with this technology, but with the light on electric field focusing become
relevant. Additionally, it allows the improvement of electric field distribution by
modification of electroporation protocol basic parameters, such as the electric
field pulse itself.
11.1. Electrode Arrays with Focusing Elements
Multielectrode electroporation applicators or electrode arrays require
complex switching systems that sequentially switch electrode pairs. Electric field
focusing can be used to simplify such electrode arrays by including “focusing
elements” which are not electrically connected to the system. The case of such
modification is shown in Figure 11.1 where the addition of focusing elements
(Figure 11.1b) improves the electric field distribution in tissue with respect of an
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electrode pair composed of two rows of needles (Figure 11.1a). This application
of the technology could be of particular importance in the case of microscopic
size systems, such microneedles fabricated with the same techniques as micro
electromechanical systems (MEMS). The need to connect all needles to make
them electrically active is no longer necessary. In this way, for example, needles
that are used to inject therapeutic molecules could serve as “focusing elements”
without the need to have an electrical potential applied to them.

Figure 11.1. Model results. Row needle electrodes and “passive electrodes”.
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11.2. Electric Field Focusing for Implants
The use electric field focusing for implantable devices, such as the
implantable glucose biosensor presented in this work presents both an
opportunity and a challenge. While electric field focusing at the site of a device’s
sensitive instrumentation is required, the excess of energy at such locations
could cause damage to the device. Figure 11.2 shows a particular case in which

Figure 11.2. Models showing donut electrodes (top) and “focusing elements”
(bottom).
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two electrodes separated by roughly 500 μm requiring a very low potential
applied between them, are embedded in the device. The figure at the top of
Figure 11.2 shows two donut shaped electrodes along the sensing element used
to apply a nominal field, the image at bottom of the figure shows that charges can
be concentrated by “focusing elements” in between the two donut electrodes.
These “focusing elements” can be conductive nanoparticles suspended or placed

Figure 11.3. Geometry (top), and model results (bottom) of implanted focusing
elements.
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on a hydrogel for example. They concentrate the intensity of the field in the outer
shell of the sensing element, while reducing the impact of the applied electric
field in other regions.
Figure 11.3 shows another example applicable to implants, in which a
sphere with “focusing elements” is used to focus the electric field applied using
superficial electrodes. The top of Figure 11.3 shows the general geometry, while
the bottom shows modeling results depicting larger magnitude electric fields at
the focusing elements.

Examples of materials that could be used are gold

conducting elements on a hydrogel (same properties as tissue) or polymer (lower
conductivity) sphere. The combination of materials such as those presented in
Chapter 7 are not explored in this model but represent a possibility for further
improving the focusing capacity of the sytem.
11.3. Electroembolization or Electrochemoembolization
Electroembolization

and

Electrochemoembolization

represent

an

opportunity to modify an existing procedure to include electroporation using the
focusing technology presented in Chapter 9.

This new technique uses the

existing microspheres that are used for embolization or chemoembolization to
deliver higher electric field intensity in tissue near the site of the microspheres. In
the unmodified procedure, microspheres are injected into the blood supply of a
tumor and due to their size (tens of micrometers) accumulate at branching
leading to smaller vesicles. The addition of electric fields is possible using the
injection catheter as one electrode and another electrode externally to the
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affected organ, or in the vein collecting the blood from the organ. The impact of
either embolization or chemoembolization could be improved by delivering
focused electric field intensities at microsphere accumulation sites.

Figure 11.4. Electrochemoembolization or electroembolization procedure.
Figure 11.4 is a 2D representation of an arterial supply to a tumor. Red
pseudocoloring represents higher electric field intensities and blue lower fields.
The arterial supply branching from left to right in this example. The needle used
to inject the microspheres is represented by a white rectangle to the left of the
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main vessel. Microspheres have accumulated at the ending branches to the
right. When an electric potential is applied using the needle, considerably larger
electric field intensities are focused at the site of the microspheres. The image
on the bottom of Figure 11.4 represents close-up of a accumulation region.
11.4. Modification of Electroporation Pulse to Improve Electric Field Distribution
Figure 9.4 shows a material that focuses electric field field intensity
transversally to the applied field in the form of a donut (in red - Figure 9.4b) when
the components of such applied field are of lower frequency than a threshold.
The material can also focus fields longitudinally to the applied field when the
frequency content is higher than a threshold frequency.

In the longitudinal

focusing, the focused field volume has the form of two bulbs (in red – Figure
9.4d).

The focusing element (shown in gray) material could be selected in

conjunction with a designed electroporation pulse that packs the necessary
frequency components to maximize the distribution of the focused fields around
the element.
The application of this technology provides an additional opportunity when
electroporating tissues that not need to include focusing elements.

In this

application, cells could serve as focusing elements, so that a pulse can be
designed to maximize distribution of electric fields in the volume without the need
of additional electrodes. Additionally, the contrast needed to focus fields can be
increased by injecting a fluid in the interstitial space that differs in electrical
characteristics from the cells.
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